Literature DB >> 30613013

[Diagnostic value of P2X7 receptor and its role in inflammatory reaction in rheumatoid arthritis].

Yonghe Chen1, Baochang Su2, Mengqiao Shang3.   

Abstract

OBJECTIVE: To study the diagnostic value of P2X7 receptor for rheumatoid arthritis (RA) and its role in the inflammatory response.
METHODS: With the synovial tissues from 25 patients with bone and joint replacement as the control,the synovial tissues of 25 RA patients were examined for the relative expression of P2X7 receptor mRNA using qRT-PCR.In an immortalized RA synovial cell line (MH7A),the effect of P2X7 receptor knockdown via a small interfering RNA were examined on the productions of the inflammatory cytokines including interleukin-1β(IL-1β),IL-6,and IL-8 using ELISA.
RESULTS: The RA patients showed significantly higher levels of P2X7 receptor mRNA expression in the synovial tissue than the control patients.P2X7 receptor had a good diagnostic value for RA.The expression levels of IL-1β,IL-6,and IL-8 were positively correlated with the levels of P2X7 receptor in the synovial tissues of RA patients (P<0.001).In MH7A cells,P2X7 receptor knockdown obviously reduced the secretion of IL-1β and IL-6.
CONCLUSIONS: RA patients show elevated P2X7 receptor level in the synovial tissue, which has a good diagnostic value for RA.Blocking P2X7 receptor can inhibit inflammatory factor secretion and suppress inflammatory reactions.

Entities:  

Keywords:  P2X7 receptor; inflammatory factor; rheumatic arthritis

Mesh:

Substances:

Year:  2018        PMID: 30613013      PMCID: PMC6744212          DOI: 10.12122/j.issn.1673-4254.2018.12.09

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  29 in total

Review 1.  P2X7 Receptor Orchestrates Multiple Signalling Pathways Triggering Inflammation, Autophagy and Metabolic/Trophic Responses.

Authors:  Elisa Orioli; Elena De Marchi; Anna Lisa Giuliani; Elena Adinolfi
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 2.  The role of exercise in the management of rheumatoid arthritis.

Authors:  George S Metsios; Antonis Stavropoulos-Kalinoglou; George D Kitas
Journal:  Expert Rev Clin Immunol       Date:  2015-07-15       Impact factor: 4.473

3.  Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate.

Authors:  Thomas C Stock; Bradley J Bloom; Nathan Wei; Saliha Ishaq; Won Park; Xin Wang; Pankaj Gupta; Charles A Mebus
Journal:  J Rheumatol       Date:  2012-03-01       Impact factor: 4.666

4.  Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis.

Authors:  T Hirano; T Matsuda; M Turner; N Miyasaka; G Buchan; B Tang; K Sato; M Shimizu; R Maini; M Feldmann
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

Review 5.  Biomarkers in Rheumatoid Arthritis.

Authors:  Fabiola Atzeni; Rossella Talotta; Ignazio F Masala; Sara Bongiovanni; Laura Boccassini; Piercarlo Sarzi-Puttini
Journal:  Isr Med Assoc J       Date:  2017-08       Impact factor: 0.892

Review 6.  P2X receptor-ion channels in the inflammatory response in adipose tissue and pancreas-potential triggers in onset of type 2 diabetes?

Authors:  Ivana Novak; Anna Solini
Journal:  Curr Opin Immunol       Date:  2018-03-06       Impact factor: 7.486

7.  P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases.

Authors:  Gloria Lopez-Castejon; Jill Theaker; Pablo Pelegrin; Andrew D Clifton; Martin Braddock; Annmarie Surprenant
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

8.  Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine.

Authors:  Edward C Keystone; Millie M Wang; Mark Layton; Sally Hollis; Iain B McInnes
Journal:  Ann Rheum Dis       Date:  2012-10       Impact factor: 19.103

Review 9.  Intracellular apoptotic pathways: a potential target for reducing joint damage in rheumatoid arthritis.

Authors:  Bonnie Williams; Anak Dharmapatni; Tania Crotti
Journal:  Inflamm Res       Date:  2017-11-21       Impact factor: 4.575

10.  The disease formerly known as rheumatoid arthritis.

Authors:  Gary S Firestein
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

View more
  1 in total

1.  [The low expression of long non-coding RNA Linc00638 contributes to rheumatoid arthritis progression by regulating inflammation and oxidative stress].

Authors:  Y Sun; J Liu; L Xin; Q Zhou; X Chen; X Ding; X Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.